The World Health Organisation (WHO) has approved a new Oral Polio Vaccine type 2 (nOPV2) made by Hyderabad-based company Biological E. Limited. This approval means the vaccine meets WHO's high ...
According to the World Health Organization, a minimum of two doses of nOPV2 are needed to interrupt poliovirus transmission. However, this will only be achieved if at least 90% of all children are ...
Hosted on MSN8mon
Biological E's nOPV2 polio vax get WHO prequalificationHYDERABAD: Biopharma player Biological E Limited (BE) has received World Health Organisation (WHO) Pre-qualification (PQ) status for its Novel Oral Polio Vaccine type 2 (nOPV2), a next-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback